Cargando…

Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications

Proteins derived from the natural extracellular matrix like collagen or gelatin are common in clinical research, where they are prized for their biocompatibility and bioactivity. Cells are able to adhere, grow and remodel scaffolds based on these materials. Usually, collagen and gelatin are sourced...

Descripción completa

Detalles Bibliográficos
Autores principales: Gellermann, Pia, Schneider-Barthold, Caroline, Bolten, Svenja Nicolin, Overfelt, Ethan, Scheper, Thomas, Pepelanova, Iliyana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787575/
https://www.ncbi.nlm.nih.gov/pubmed/31480684
http://dx.doi.org/10.3390/jfb10030039
_version_ 1783458295151853568
author Gellermann, Pia
Schneider-Barthold, Caroline
Bolten, Svenja Nicolin
Overfelt, Ethan
Scheper, Thomas
Pepelanova, Iliyana
author_facet Gellermann, Pia
Schneider-Barthold, Caroline
Bolten, Svenja Nicolin
Overfelt, Ethan
Scheper, Thomas
Pepelanova, Iliyana
author_sort Gellermann, Pia
collection PubMed
description Proteins derived from the natural extracellular matrix like collagen or gelatin are common in clinical research, where they are prized for their biocompatibility and bioactivity. Cells are able to adhere, grow and remodel scaffolds based on these materials. Usually, collagen and gelatin are sourced from animal material, risking pathogenic transmission and inconsistent batch-to-batch product quality. A recombinant production in yeast circumvents these disadvantages by ensuring production with a reproducible quality in animal-component-free media. A gelatin mimetic protein, based on the alpha chain of human collagen I, was cloned in Pichia pastoris under the control of the methanol-inducible alcohol oxidase (AOX1) promoter. A producing clone was selected and cultivated at the 30 L scale. The protein was secreted into the cultivation medium and the final yield was 3.4 g·L(−1). Purification of the target was performed directly from the cell-free medium by size exclusion chromatography. The gelatin mimetic protein was tested in cell culture for biocompatibility and for promoting cell adhesion. It supported cell growth and its performance was indistinguishable from animal-derived gelatin. The gelatin-mimetic protein represents a swift strategy to produce recombinant and human-based extracellular matrix proteins for various biomedical applications.
format Online
Article
Text
id pubmed-6787575
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67875752019-10-16 Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications Gellermann, Pia Schneider-Barthold, Caroline Bolten, Svenja Nicolin Overfelt, Ethan Scheper, Thomas Pepelanova, Iliyana J Funct Biomater Article Proteins derived from the natural extracellular matrix like collagen or gelatin are common in clinical research, where they are prized for their biocompatibility and bioactivity. Cells are able to adhere, grow and remodel scaffolds based on these materials. Usually, collagen and gelatin are sourced from animal material, risking pathogenic transmission and inconsistent batch-to-batch product quality. A recombinant production in yeast circumvents these disadvantages by ensuring production with a reproducible quality in animal-component-free media. A gelatin mimetic protein, based on the alpha chain of human collagen I, was cloned in Pichia pastoris under the control of the methanol-inducible alcohol oxidase (AOX1) promoter. A producing clone was selected and cultivated at the 30 L scale. The protein was secreted into the cultivation medium and the final yield was 3.4 g·L(−1). Purification of the target was performed directly from the cell-free medium by size exclusion chromatography. The gelatin mimetic protein was tested in cell culture for biocompatibility and for promoting cell adhesion. It supported cell growth and its performance was indistinguishable from animal-derived gelatin. The gelatin-mimetic protein represents a swift strategy to produce recombinant and human-based extracellular matrix proteins for various biomedical applications. MDPI 2019-09-02 /pmc/articles/PMC6787575/ /pubmed/31480684 http://dx.doi.org/10.3390/jfb10030039 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gellermann, Pia
Schneider-Barthold, Caroline
Bolten, Svenja Nicolin
Overfelt, Ethan
Scheper, Thomas
Pepelanova, Iliyana
Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications
title Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications
title_full Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications
title_fullStr Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications
title_full_unstemmed Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications
title_short Production of a Recombinant Non-Hydroxylated Gelatin Mimetic in Pichia pastoris for Biomedical Applications
title_sort production of a recombinant non-hydroxylated gelatin mimetic in pichia pastoris for biomedical applications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787575/
https://www.ncbi.nlm.nih.gov/pubmed/31480684
http://dx.doi.org/10.3390/jfb10030039
work_keys_str_mv AT gellermannpia productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications
AT schneiderbartholdcaroline productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications
AT boltensvenjanicolin productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications
AT overfeltethan productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications
AT scheperthomas productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications
AT pepelanovailiyana productionofarecombinantnonhydroxylatedgelatinmimeticinpichiapastorisforbiomedicalapplications